Riccardo Mazza: Do Weight, BMI, and Renal Function Independently Predict Acute Events in NVAF Patients on DOACs?
Riccardo Mazza, Cardiology Resident at University Vita-Salute San Raffaele, shared a post on LinkedIn about a recent article and his colleagues co-authored, adding:
“DOACs: Not weight.
Not renal function.
It’s plasma levels.
In our latest research letter, we addressed a key clinical question:
Do weight, BMI, and renal function independently predict acute events in NVAF patients on DOACs?
Short answer: they do not – once drug exposure is accounted for.
Our findings suggest a mediated effect: renal function influences outcomes through modulation of DOAC plasma levels, rather than acting as an independent determinant.
Clinical implications:
Weight and renal function remain essential for dose selection.
However, when it comes to actual patient risk, the key determinant may be:
- true pharmacological exposure
In other words:
We dose based on patient characteristics – but outcomes are driven by drug levels.
Link to the Research Letter in the first comment.
Grateful to the entire team Cosmo Godino, Carlo Gaspardone, Anna Salerno, Massimo Slavich, Rachele Sena.”
Title: Beyond Weight and Renal Function: DOAC Plasma Levels Remain the Primary Determinant of Acute Outcomes—A Re-Analysis of the 4Levels Study
Authors: Riccardo Mazza, Carlo Gaspardone, Chiara Miranda, Sofia Di Bisceglie, Alessia Minerva, Rachele Sena, Gianmarco Cozzani, Anna Salerno, Michela Cera, Massimo Slavich, Leila Anna De Lorenzo, Giulio Leo, Giulia Nemola, Annalisa Fattorini, Luciano Crippa, Patrizia Della Valle, Alberto Margonato, Armando D’Angelo, Cosmo Godino
Read the Full Article on Clinical Therapeutics
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia